StocksRunner logo
mail
search
 
menu
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  Headlines  
 
  Updates  
 
 
Biora Therapeutics
0.75
+3.79%
 
 
 

BIOR

 

Biora Therapeutics

$0.75

 
+$0.03 | +3.79%
 
Open
$ 0.72
 
 
MKT CAP
$ 26.82M
 
High
$ 0.75
 
 
VOL
$ 142.46K
 
Low
$ 0.71
 
 
AVG VOL
$ 0.29M
 
 
 

BIOR Stock Rating Review

 
Biora Therapeutics (BIOR) still has no score becuse there is not enough information which allows us to analyze the activity of the company over a period of time
 
 

BIOR Total Score

 
 
 

Chart

 
 

0.75

1.19

1.12

1.12

 
 
1month
3month
6month
1year
 
Total Return
BIOR
vs.
S&P500
 

 
1-week Return
+1.35%
 
+1.32%
 
 
5-week Return
+2.74%
 
+4.00%
 
 
10-week Return
+4.17%
 
+5.53%
 
 
 

BIOR Risk Level

 

This Indicator assigning BIOR risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
BIOR Risk Level
LOW
HIGH

Risk Volatility

 

BIOR has Extreme Risk Level

Click here to check what is your level of risk

 

BIOR Analysts Opinion

 

BIOR overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

NA
 
 
 

Rating

×
 

Rating

NA
 
 

Momentum

×
 

Momentum

NA
 

BIOR Momentum Analysis

 Price value has negative momentum

 

Activity

×
 

Activity

NA
 
 

Future

×
 

Future

NA
 
 
 

 

BIOR Street Consensus

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
0%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
NA
NA
NA
 
 

BIOR Performance Sentiment

 
Sentiments overview associated with BIOR events and the stock performance.
 
0%
0%
Positive
Negative
No Events Found
events present

events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

BIOR Earnings

 

The TTM reflects 12-month period, providing review of BIOR financial performance.

 
Millions of Dollars
TTM
2023
2022
CAGR
 

 
Total Revenue
1
-
 
 
Cost of Revenue
-
-
-
-
 
 
Gross Profit
-
-
-
-
 
 
Operating Exp
68
67
62
+4.73%
 
 
Operating Inc
-67
-67
-62
-
 
 
Net Interest Inc
-10
-10
-11
-
 
 
Interest Exp
10
10
11
-4.65%
 
 
Interest Inc
-
-
-
 
 
Other Inc Exp
-34
-47
24
-
 
 
EPS Growth
-
 
 

BIOR Financial Health

 

The company financial health has moderately improved over the past year, reflecting average market demand and somewhat effective business strategies. There have been noticeable gains in profitability and cost management, but there is still substantial room for growth and optimization.

 

Financial Score

 
3.26
 
Next Earnings Date: Aug 12, 2024
 
 
Linked to BIOR
Total Score
Close Price
% Change

 

AZN

Astrazeneca

4.07

79.59

+0.08%

 
 
 
Headlines
Last Modify
Price
% Change

 
 
BIOR Latest News +
 
 
StocksRunner

Explore our BIOR Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored BIOR Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our BIOR Daily Alerts

Access the exclusive insights that over 10,000+ subscribers value. Stay ahead in the stock market! Submit your email for daily alerts.

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo

StocksRunner

Get the pulse of the market

 
 
StocksRunner
 
 
StocksRunner
Overview
 
StocksRunner
Trending
 
StocksRunner
Screener
 
StocksRunner
Ideas
 
StocksRunner
Top Rated
 
StocksRunner
Momentum
 
StocksRunner
Earnings
 
 
 
 
 

Stock Insights

 
 
 

Not Enough Information

 
 
 

BIOR Risk Level

 
 
 

The Indicator assigning BIOR risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
 
BIOR Risk Level
LOW
HIGH

Risk Volatility

 

BIOR has Extreme Risk Level. Click here to check what is your level of risk

 
 
 
 

Stock Analysis

 
 
 
 

BIOR

 

Biora Therapeutics

$0.75

 
+$0.03 | +3.79%
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  Headlines  
 
  Updates  
 

 
Open
$ 0.72
 
 
MKT CAP
$ 26.82M
 
High
$ 0.75
 
 
VOL
$ 142.46K
 
Low
$ 0.71
 
 
AVG VOL
$ 0.29M
 
 
 

BIOR Stock Rating

 
Biora Therapeutics (BIOR) still has no score becuse there is not enough information which allows us to analyze the activity of the company over a period of time
 
 

Chart

 
 

0.75

1.19

1.12

1.12

 
 
1month
3month
6month
1year
 
Total Return
BIOR
vs.
S&P500
 

 
1-week Return
+1.35%
 
+1.32%
 
 
5-week Return
+2.74%
 
+4.00%
 
 
10-week Return
+4.17%
 
+5.53%
 
 
 

BIOR Analysts Opinion

 

BIOR Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

NA
 
 
 

Rating

×
 

Rating

NA
 
 

Momentum

×
 

Momentum

NA
 

BIOR Momentum Sentiment

 Price value has negative momentum

 

Activity

×
 

Activity

NA
 
 

Future

×
 

Future

NA
 
 
 

 

BIOR Street Consensus

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
0%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
NA
NA
NA
 
 
BIOR Performance Sentiment
 
Sentiments overview associated with BIOR events and the stock performance.
 
0%
0%
Positive
Negative
No Events Found
events present

events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

BIOR Earnings

 

The TTM data reflects the most recent 12-month period, providing overview of BIOR financial performance.

 
Millions of Dollars
TTM
2023
2022
CAGR
 

 
Total Revenue
1
-
 
 
Cost of Revenue
-
-
-
-
 
 
Gross Profit
-
-
-
-
 
 
Operating Exp
68
67
62
+4.73%
 
 
Operating Inc
-67
-67
-62
-
 
 
Net Interest Inc
-10
-10
-11
-
 
 
Interest Exp
10
10
11
-4.65%
 
 
Interest Inc
-
-
-
 
 
Other Inc Exp
-34
-47
24
-
 
 
EPS Growth
-
 
 

BIOR Financial Health

 

The company financial health has moderately improved over the past year, reflecting average market demand and somewhat effective business strategies. There have been noticeable gains in profitability and cost management, but there is still substantial room for growth and optimization.

 

Financial Score

 
3.26
 
Next Earnings Date: Aug 12, 2024
 
Headlines
Last Modify
Price
% Change

 
 
BIOR Latest News +
 
 
 
 
 

Score Tracker

 
 
 
Based on 0 events in the last 90 days from financial news and social media. Last updated Jun 14, 2024 10:54 Wall St. time
 
 

BIOR Total Score

 
 
 
 
 

Linked to BIOR

 
 
 
Symbol
Score
% Change
 

AZN

Astrazeneca

4.07

+0.08%

79.59

 
 
 
 
 
 
StocksRunner

Discover BIOR Stock analysis and effective trading strategies with StocksRunner. Gain valuable insights into stock performance, market trends, and the future potential of BIOR. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our BIOR Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

BIOR Stock trends

BIOR Stock performance

BIOR Stock analysis

BIOR investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
Post ×
 
0/666
joker